Allgens Medical Technology, a leading company in artificial bone repair materials, disclosed that shareholders Cui Han and Hu Gang have proposed adding a motion to remove Ms. Huang Wanlan from her position as company director at the first extraordinary general meeting of 2026. Cui Han, Hu Gang, and Huang Wanlan are all actual controllers of the company. Huang Wanlan currently serves as chairwoman, Cui Han is an employee director, Cui Han and Hu Gang are a married couple, and Huang Wanlan is Cui Han's mother. The company responded that operations and management are currently stable, and the proposal stems from internal personal conflicts. Huang Wanlan directly holds 5.53 percent of shares and controls a further 5.66 percent equity stake through Yinhe Jiutian, where she acts as executive partner. Cui Han and Hu Gang together hold 8.76 percent of shares. The shareholders' meeting will deliberate on four motions, including the removal proposal, on July 20.
Allgens Medical Technology Co. Ltd. AProposal to remove chairwoman Huang Wanlan due to internal personal conflicts creates governance uncertainty.